Switzerland· 56133003
Wilate 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
A von willebrand-faktor und faktor viii in kombination product containing factor viii coagulationis humanus, factor humanus von willebrandi, registered in Switzerland by Octapharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Von willebrand-faktor und faktor viii in kombination is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD06 (von willebrand-faktor und faktor viii in kombination), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Von willebrand-faktor und faktor viii in kombination · ATC B02BD06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- factor VIII coagulationis humanus, factor humanus von Willebrandi
- Manufacturer
- Octapharma AG
- Country
- Switzerland (CH)
- ATC code
- B02BD06
- ATC class
- von Willebrand-Faktor und Faktor VIII in Kombination
- Defined daily dose
- 1 TSD, E
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680561330032Durchstf 1 StkCHF 400
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BD06
Von willebrand-faktor und faktor viii in kombination, as other registers publish it.
- PolandFANHDIInstituto Grifols S.A.
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- PolandFANHDIInstituto Grifols S.A.
- PolandFANHDIInstituto Grifols S.A.
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- FinlandHaemateCSL Behring GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e497e4ce-a6ff-499a-ac60-5c3cd0114f74 GET /v1/drugs/e497e4ce-a6ff-499a-ac60-5c3cd0114f74?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "factor viii coagulationis humanus 500 UI + factor humanus von willebrandi 500 UI",
"valid_from": "2014-04-01",
"limitations": null,
"galenic_form": "Trockensub 500 IE c Solv",
"therapeutic_area": null,
"sl_inclusion_date": "2014-04-01",
"self_retention_pct": 10
}See everything about von willebrand-faktor und faktor viii in kombination.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.